Key facts
- ID Nest Medical’s last known valuation is $11.4M (Jul 2025).
- It has raised $3.4M; the latest was Later Stage VC ($590K) in Jul 2025.
- Notable investors include Bpifrance, Alsace BioValley, Alsace Business Angels, Conectus, IPSA group (France) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for ID Nest Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for ID Nest Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ID Nest Medical
Developer of a medical device designed to assist in the treatment of aortic arch aneurysms. The company's device restores the functionality of vascular bifurcations by resolving the connection problem, using different approaches for the parent endoprosthesis and the branches, enabling medical professionals to treat their patients suffering from aortic arch aneurysms.
- Sector
- Healthcare
- HQ
- Strasbourg, France
- Founded
- 2010
- Employees
- 3
- Website
- idnest-medical.com/
- Ownership
- Privately Held (backing)
ID Nest Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ID Nest Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ID Nest Medical in its N-PORT filings yet. We sweep new filings monthly.